← Open Payments lookup

LLOYD HATTON: Open Payments

NPI 1972138170 · SHERMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,073 in 117 payments from 15 companies in 2025. Trend: 2023 $2,523 · 2024 $1,915 · 2025 $2,073

Food & beverage: $2,073
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.21$353
Lundbeck LLC13$250
Vanda Pharmaceuticals Inc.13$231
Teva Pharmaceuticals USA, Inc.13$228
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$225
ABBVIE INC.14$187
Neurocrine BioSciences, Inc.10$168
Janssen Pharmaceuticals, Inc7$152
Axsome Therapeutics, Inc.4$72
E.R. Squibb & Sons, L.L.C.4$70

Products named: REXULTI, FANAPT, CAPLYTA, VRAYLAR, INGREZZA, AUSTEDO XR, INVEGA SUSTENNA, UZEDY.

Industry payments across TX — which companies pay providers there.